Scarica l'app Stockscreener
1.23
7.52%
-0.10
Dopo l'orario di chiusura:
1.17
-0.06
-4.88%
Precedente Chiudi:
$1.33
Aprire:
$1.3
Volume 24 ore:
160.80K
Relative Volume:
1.67
Capitalizzazione di mercato:
$10.41M
Reddito:
$10.16M
Utile/perdita netta:
$-47.57M
Rapporto P/E:
-0.1493
EPS:
-8.24
Flusso di cassa netto:
$-42.73M
1 W Prestazione:
-46.98%
1M Prestazione:
-58.72%
6M Prestazione:
-75.79%
1 anno Prestazione:
-92.32%
Intervallo 1D:
$1.19
$1.4221
Intervallo di 1 settimana:
$1.19
$2.36
Portata 52W:
$1.19
$17.49
Curis Inc Stock (CRIS) Company Profile
Nome
Curis Inc
Settore
Industria
Telefono
617-503-6500
Indirizzo
128 SPRING STREET, LEXINGTON, MA
Confronta CRIS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.23 | 10.41M | 10.16M | -47.57M | -42.73M | -8.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-17 | Iniziato | Truist | Buy |
| 2022-04-04 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2020-07-29 | Iniziato | Laidlaw | Buy |
| 2020-07-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-10-24 | Iniziato | Guggenheim | Buy |
| 2016-03-02 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | Reiterato | ROTH Capital | Buy |
| 2015-08-11 | Iniziato | FBR Capital | Outperform |
| 2015-01-22 | Reiterato | Oppenheimer | Outperform |
| 2015-01-21 | Reiterato | ROTH Capital | Buy |
| 2014-05-09 | Reiterato | Oppenheimer | Outperform |
| 2013-10-02 | Iniziato | Robert W. Baird | Outperform |
| 2013-09-30 | Iniziato | Chardan Capital Markets | Buy |
| 2012-11-14 | Iniziato | Stifel Nicolaus | Hold |
| 2012-01-31 | Reiterato | Brean Murray | Buy |
| 2012-01-31 | Reiterato | Summer Street Research | Buy |
| 2011-12-09 | Iniziato | Oppenheimer | Outperform |
| 2011-10-06 | Iniziato | Summer Street Research | Buy |
| 2011-09-22 | Iniziato | MLV Capital | Buy |
| 2011-03-21 | Reiterato | Brean Murray | Buy |
| 2010-02-26 | Reiterato | Roth Capital | Buy |
| 2010-01-07 | Iniziato | Roth Capital | Buy |
Mostra tutto
Curis Inc Borsa (CRIS) Ultime notizie
HC Wainwright Forecasts Curis’ Q1 Earnings (NASDAQ:CRIS) - Defense World
Analyst Forecasts For Curis, Inc. (NASDAQ:CRIS) Are Surging Higher - Yahoo Finance
Curis targets accelerated approval for emavusertib in PCNSL with 12-18 month enrollment timeline - MSN
Curis to Present at Upcoming Healthcare Conference in April 2025 - BioSpace
Curis Spotlights Game-Changing IRAK4 Cancer Drug: CEO Details Development Pipeline - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Analysts Just Published A Bright New Outlook For Curis, Inc.'s (NASDAQ:CRIS) - simplywall.st
Curis stock price target cut to $16 by H.C. Wainwright - Investing.com Australia
Curis stock plunges to 52-week low at $1.97 amid market challenges - Investing.com
Curis, Inc. (NASDAQ:CRIS) Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance
Curis, Inc. (NASDAQ:CRIS) Q4 2024 Earnings Call Transcript - Insider Monkey
Investors Don't See Light At End Of Curis, Inc.'s (NASDAQ:CRIS) Tunnel And Push Stock Down 30% - simplywall.st
Curis: Q4 Earnings Snapshot - CT Insider
Curis Inc (CRIS) Q4 2024 Earnings Call Highlights: Financial Improvements and Promising ... - Yahoo Finance
Curis stock plunges to 52-week low at $1.97 amid market challenges By Investing.com - Investing.com South Africa
Curis (NASDAQ:CRIS) Price Target Lowered to $16.00 at HC Wainwright - Defense World
Curis Inc. Reports Q4 2024 Progress and Financials - TipRanks
Curis Inc. Earnings Call: Progress Amidst Challenges - TipRanks
Curis eyes accelerated approval for cancer drug emavusertib By Investing.com - Investing.com South Africa
Earnings call transcript: Curis Q4 2024 reveals reduced losses - Investing.com India
Curis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Curis Q4 2024 reveals reduced losses By Investing.com - Investing.com UK
Curis eyes accelerated approval for cancer drug emavusertib - Investing.com India
Curis Provides Fourth Quarter 2024 Business Update - PR Newswire
Curis Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Curis (NASDAQ:CRIS) Coverage Initiated at StockNews.com - Defense World
Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025 - Quantisnow
Biotech Alert: Curis Sets Date for Q4 EarningsKey Updates on IRAK4 Inhibitor Program Expected - Stock Titan
Curis Inc Entered A Purchase Agreement To Sell 2 Million Shares Of Common Stock - Marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Curis stock hits 52-week low at $2.54 amid sharp annual decline - Investing.com Australia
Curis stock hits 52-week low at $2.54 amid sharp annual decline By Investing.com - Investing.com South Africa
StockNews.com Initiates Coverage on Curis (NASDAQ:CRIS) - Defense World
Health Care Providers To Pay Back Almost $2 Million In Medicare Fraud - Newsweek
Curis stock touches 52-week low at $2.83 amid sharp yearly decline - Investing.com Australia
Curis Inc faces potential Nasdaq delisting By Investing.com - Investing.com Australia
Curis, Inc. to Host Earnings Call - ACCESS Newswire
Curis Inc faces potential Nasdaq delisting - Investing.com
Investor Network: Curis, Inc. to Host Earnings Call - ACCESS Newswire
Curis (CRIS) Expected to Announce Quarterly Earnings on Thursday - Defense World
CURIS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
BostInnoHappy New Year! | Inno Approved Events - The Business Journals
Diddy, Jay-Z Rape Lawsuit Dropped Amid Legal Ethics Battle - Law360
CRISCuris Provides Second Quarter 2024 Financial and Operating Update - br.ADVFN.com
Curis (CRIS) Projected to Post Earnings on Thursday - Defense World
Jay-Z Sex Assault Suit Invalid Under Law, Rapper Says - Law360
Jay-Z Blasts Buzbee For 'Reputation-Destroying Allegations' - Law360
Curis Inc Azioni (CRIS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):